Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Jun;61(6):2017-23.
doi: 10.1128/JVI.61.6.2017-2023.1987.

Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection

Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection

B Wahren et al. J Virol. 1987 Jun.

Abstract

The human immunodeficiency virus (HIV)-specific lymphocyte proliferation response was determined for 40 persons at different stages of HIV infection. The specific response to purified HIV virion antigens from strain HTLV-IIIB was poor, occurred in only 9 of the 40 subjects, was not improved with the addition of interleukin-2, and was more frequent in symptom-free individuals (46%) than in patients with lymphadenopathy syndrome (10%). Reactivity to subcomponent p24 was better than that to whole HIV; reactivity was present in five of six infected persons and increased with the addition of exogenous interleukin-2. Reactivities to subcomponents (g)p41 and gp120 were also measured. This is the first evidence of a specific cell-mediated immune response to HIV antigen in HIV-infected persons. Monkeys immunized with purified HIV or with purified p24 displayed cellular immunoreactivity both to whole HIV and to subcomponents. In contrast to the poor reactivity to HIV antigen, the lymphocytes of the patients had good specific cell proliferation responses to cytomegalovirus and herpes simplex virus challenge and a normal response to the addition of phytohemagglutinin. The results suggest a functional defect in peripheral lymphocytes of some HIV-infected individuals on the basis of their response to whole HIV antigen and a better response to gag protein.

PubMed Disclaimer

References

    1. N Engl J Med. 1977 Jun 16;296(24):1372-7 - PubMed
    1. Lancet. 1985 Jun 29;1(8444):1480-2 - PubMed
    1. J Virol Methods. 1981 Apr;2(5):301-12 - PubMed
    1. Lancet. 1982 Apr 17;1(8277):908 - PubMed
    1. N Engl J Med. 1982 Jul 1;307(1):7-13 - PubMed

Publication types

MeSH terms

Substances